Australia is investigating whether a blood clotting disorder case recorded on Friday is related to the AstraZeneca coronavirus vaccine, Deputy Chief Medical Officer Professor Michael Kidd said.
Australian media reported that a 44-year-old man was admitted to a Melbourne hospital with possible clotting days after receiving the vaccine.
Get weekly health news
“Investigators have not at this time confirmed a causal link with the COVID-19 AstraZeneca vaccine, but investigations are ongoing,” Kidd told a televised briefing.
- Public health warns of potential chickenpox exposure at Peterborough Regional Health Centre
- Province invests millions in funding for Kingston cancer research
- Labour, birth services at N.B. hospital ‘temporarily diverted’ due to nurse shortage
- Calgary Stampede unveils long list of ‘outrageous’ midway foods for 2026
-
![]()
Police enforce boat safety ahead of Victoria Day long weekend -
![]()
Health Matters: Passengers disembark norovirus-hit cruise ship -
![]()
Hantavirus outbreak: Canada now considers all passengers, crew of MV Hondius to be ‘high-risk’ -
![]()
New partnership focusing on local prostate cancer research based in Saskatchewan
He added that more details are expected to be known on Saturday.
Australia’s Therapeutic Goods Administration (TGA), the medicine and therapeutic regulatory agency, has said previously that AstraZeneca vaccine was not associated with an increase in the overall risk of blood clots.
(Reporting by Lidia Kelly; Editing by Kim Coghill)
Comments
Want to discuss? Please read our Commenting Policy first.